NCT06405503View on ClinicalTrials.gov

Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease

Not yet recruitingOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Inflammatory Bowel Disease
Interventions
OTHER

NO INTERVENTION

NO INTERVENTION - OBSERVATIONAL ONLY

Trial Locations (1)

78712

Dell Medical School at the University of Texas at Austin, Austin

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Yale University

OTHER

lead

University of Texas at Austin

OTHER